211 related articles for article (PubMed ID: 8632904)
1. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
Tsang SX; Morris GF; Lu M; Morris CB
Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
[TBL] [Abstract][Full Text] [Related]
2. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
4. Modulation of transcriptional activation of the proliferating cell nuclear antigen promoter by the adenovirus E1A 243-residue oncoprotein depends on proximal activators.
Morris GF; Labrie C; Mathews MB
Mol Cell Biol; 1994 Jan; 14(1):543-53. PubMed ID: 7903420
[TBL] [Abstract][Full Text] [Related]
5. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
Kannabiran C; Morris GF; Mathews MB
Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
[TBL] [Abstract][Full Text] [Related]
6. A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.
Labrie C; Morris GF; Mathews MB
Mol Cell Biol; 1993 Mar; 13(3):1697-707. PubMed ID: 8095093
[TBL] [Abstract][Full Text] [Related]
7. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
8. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
Song CZ; Loewenstein PM; Green M
J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
10. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
[TBL] [Abstract][Full Text] [Related]
11. Transforming region of 243R E1A contains two overlapping but distinct transactivation domains.
Sang N; Claudio PP; Fu Y; Horikoshi N; Graeven U; Weinmann R; Giordano A
DNA Cell Biol; 1997 Nov; 16(11):1321-33. PubMed ID: 9407004
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.
Song CZ; Loewenstein PM; Toth K; Green M
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10330-3. PubMed ID: 7479778
[TBL] [Abstract][Full Text] [Related]
13. The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter.
Kannabiran C; Morris GF; Labrie C; Mathews MB
J Virol; 1993 Jan; 67(1):507-15. PubMed ID: 8093222
[TBL] [Abstract][Full Text] [Related]
14. The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB.
Song CZ; Loewenstein PM; Toth K; Tang Q; Nishikawa A; Green M
Mol Cell Biol; 1997 Apr; 17(4):2186-93. PubMed ID: 9121468
[TBL] [Abstract][Full Text] [Related]
15. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.
Kilbourne EJ; Evans MJ; Karathanasis SK
Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550
[TBL] [Abstract][Full Text] [Related]
16. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.
Parker SF; Felzien LK; Perkins ND; Imperiale MJ; Nabel GJ
J Virol; 1997 Mar; 71(3):2004-12. PubMed ID: 9032332
[TBL] [Abstract][Full Text] [Related]
17. Repression of liver-specific hepatitis B virus enhancer 2 activity by adenovirus E1A proteins.
Chen ST; Su H; Yee JK
J Virol; 1992 Dec; 66(12):7452-60. PubMed ID: 1331530
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.
Ge R; Kralli A; Weinmann R; Ricciardi RP
J Virol; 1992 Dec; 66(12):6969-78. PubMed ID: 1433502
[TBL] [Abstract][Full Text] [Related]
19. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression.
Horikoshi N; Usheva A; Chen J; Levine AJ; Weinmann R; Shenk T
Mol Cell Biol; 1995 Jan; 15(1):227-34. PubMed ID: 7799929
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A represses the cyclic AMP-induced transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in hepatoma cells.
Kalvakolanu DV; Liu J; Hanson RW; Harter ML; Sen GC
J Biol Chem; 1992 Feb; 267(4):2530-6. PubMed ID: 1310318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
